Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptive Biotechnologies Corporation logo

Chief Commercial Officer, MRD Bobulsky Susan sold $95,000 worth of shares (5,000 units at $19.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 411,775 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADPT (Adaptive Biotechnologies Corporation) and more on Quantisnow.